Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2025 Earnings Call Transcript May 13, 2025
Fennec Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.12.
Operator: Good morning, ladies and gentlemen. And welcome to Fennec Pharmaceuticals First Quarter 2025 Earnings and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions on how to participate...
